{"id":923,"date":"2017-09-04T16:02:07","date_gmt":"2017-09-04T15:02:07","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=923"},"modified":"2017-09-04T16:07:12","modified_gmt":"2017-09-04T15:07:12","slug":"gilead-hiv-medication-lawsuit-reinstated","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated","title":{"rendered":"Gilead HIV medication lawsuit reinstated"},"content":{"rendered":"

Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with the lawsuit filed in 2011 against them that they may have considered to have ended.<\/p>\n

A federal appeals court has recently reinstated the lawsuit that was brought by two whistle-blowers alleging that Gilead defrauded and misled the government, as the company allegedly didn’t disclose that their HIV medicines were contaminated<\/strong>, which consequently allowed them to reportedly falsify data to win marketing approval for the medicine.<\/p>\n

This false information reportedly led federal healthcare programmes to pay billions of dollars for contaminated medicine, but the case was initially dismissed by the California Court.<\/p>\n

Now, it’s back…
\n<\/p>\n

Allegations<\/h2>\n

Recently, the Ninth Circuit Court of Appeals in San Francisco ruled that the claims made by former employees, Jeff and Sherilyn Campie, satisfy the requirements of a False Claims Act complaint. The basis of their claim falls on the fact that Gilead reportedly used synthetic ingredients from a manufacturer in China to lower the production costs of its HIV drugs.<\/p>\n

This was not the problem, though; the problem was that the company then allegedly concealed the nature of these ingredients when it sought approval from the U.S. Food and Drug Administration (FDA) for the HIV drugs. They allegedly protested that the ingredient was supplied from South Korea and was FDA-approved, but that was apparently far from the truth.<\/p>\n

They “also allege Gilead hid or falsified certain data to aid in their subsequent bid for FDA approval of the Chinese ingredients.” The allegations also extended to Gilead reportedly making false statements to the government and failing to tell the FDA of its additional ingredients. They allegedly tried to hide the ingredients<\/strong> by making up inventory codes as well as mislabelling and altering shipping and tracking information to allegedly conceal the origin of ingredients.<\/p>\n

The main ingredients that are used in HIV medicines that were imported and hid were Emtriva, Truvada and Atripla. Some of the unapproved emtricitabine didn’t pass Gilead’s internal quality tests, and the results of this were then reportedly hidden from the FDA.<\/p>\n

Impact on individuals and the government<\/h3>\n

The resurrection of the case isn’t just important for the government to regulate the potential impurities of the drug market, but it may also have a huge effect on individuals who have, or will take, the medicine.<\/p>\n

It’s also potentially had an impact on government funding for programmes such as Medicare and Medicaid. Between 2008 and 2009, the U.S. government reportedly spent $5 billion (\u00a33.8 billion) on Emtriva, Truvada and Atripla.<\/p>\n

Gilead’s pricing spike<\/h3>\n

In January 2016, Massachusetts’ Attorney General opened an investigation after allegations arose that the company was charging patients too much for its Hepatitis C and HIV drugs, which violated state consumer protection laws.<\/p>\n

Hepatitis C drugs have been scientifically proven to cure patients in approximately 12 weeks. One of the Hepatitis C drugs cost $84,000 (\u00a364,000) for a 12 week treatment. The prices set by companies like Gilead have reportedly strained the budgets of government-funded care such as Medicaid, which may have forced the government to curtail treatment to the most needy.<\/p>\n

John Martin highlights the danger that came with Gilead’s allegedly unfair pricing: <\/p>\n

“…because Gilead’s drugs offer a cure for a serious and life-threatening infectious disease, pricing the treatment in a manner that effectively allows H.C.V. to continue spreading through vulnerable populations, as opposed to eradicating the disease altogether, results in massive public harm.”<\/em><\/strong><\/p><\/blockquote>\n

Image Credit: https:\/\/pixabay.com\/en\/science-biology-test-tube-liquid-1336663\/<\/a><\/small><\/p>\n","protected":false},"excerpt":{"rendered":"

Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with the lawsuit filed in 2011 against them that they may have considered to have ended. A federal appeals court has recently reinstated the lawsuit that was brought by two whistle-blowers alleging that Gilead defrauded and misled the government, as the company allegedly … Continue reading Gilead HIV medication lawsuit reinstated<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5],"tags":[19],"class_list":["post-923","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","tag-lawsuits"],"yoast_head":"\nGilead HIV medication lawsuit reinstated - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead HIV medication lawsuit reinstated - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-04T15:02:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-09-04T15:07:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-large-min.png?fit=1200%2C680&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"680\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-large-min.png?fit=1200%2C680&ssl=1\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"headline\":\"Gilead HIV medication lawsuit reinstated\",\"datePublished\":\"2017-09-04T15:02:07+00:00\",\"dateModified\":\"2017-09-04T15:07:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated\"},\"wordCount\":582,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1\",\"keywords\":[\"lawsuits\"],\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated\",\"name\":\"Gilead HIV medication lawsuit reinstated - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2017-09-04T15:02:07+00:00\",\"dateModified\":\"2017-09-04T15:07:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"description\":\"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1\",\"width\":725,\"height\":250,\"caption\":\"gilead lawsuit\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/gilead-hiv-medication-lawsuit-reinstated#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead HIV medication lawsuit reinstated\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead HIV medication lawsuit reinstated - Group Action Lawyers","description":"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated","og_locale":"en_GB","og_type":"article","og_title":"Gilead HIV medication lawsuit reinstated - Group Action Lawyers","og_description":"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated","og_site_name":"Group Action Lawyers","article_published_time":"2017-09-04T15:02:07+00:00","article_modified_time":"2017-09-04T15:07:12+00:00","og_image":[{"width":1200,"height":680,"url":"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-large-min.png?fit=1200%2C680&ssl=1","type":"image\/png"}],"author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-large-min.png?fit=1200%2C680&ssl=1","twitter_misc":{"Written by":"Admin","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated"},"author":{"name":"Admin","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"headline":"Gilead HIV medication lawsuit reinstated","datePublished":"2017-09-04T15:02:07+00:00","dateModified":"2017-09-04T15:07:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated"},"wordCount":582,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1","keywords":["lawsuits"],"articleSection":["Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated","name":"Gilead HIV medication lawsuit reinstated - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1","datePublished":"2017-09-04T15:02:07+00:00","dateModified":"2017-09-04T15:07:12+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"description":"Gilead Sciences Inc, a research-based biopharmaceutical company, has recently experienced a set-back with a lawsuit filed against them back in 2011.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1","width":725,"height":250,"caption":"gilead lawsuit"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/gilead-hiv-medication-lawsuit-reinstated#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Gilead HIV medication lawsuit reinstated"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gilead-lawsuit-min.png?fit=725%2C250&ssl=1","jetpack-related-posts":[{"id":1183,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/boston-scientific-20-million-pelvic-mesh-lawsuit-appeal-dismissed","url_meta":{"origin":923,"position":0},"title":"Court dismisses Boston Scientific’s appeal over \u00a320 million settlement for pelvic mesh lawsuit","author":"Admin","date":"18th December 2017","format":false,"excerpt":"A federal court has dismissed Boston Scientific's appeal against a \u00a320 million settlement sum awarded to four claimants who sued the company for alleged defective pelvic mesh implants. The claimants argued that the Pinnacle mesh used to treat pelvic organ prolapse and female stress urinary incontinence was defective and caused\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"vaginal mesh implant inquiry","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/vaginal-mesh-implant-inquiry-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/vaginal-mesh-implant-inquiry-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/vaginal-mesh-implant-inquiry-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/vaginal-mesh-implant-inquiry-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":980,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/jetblue-airways-sued-violent-turbulence-injuring-27","url_meta":{"origin":923,"position":1},"title":"JetBlue Airways sued for violent turbulence, injuring 27 on board","author":"Admin","date":"29th September 2017","format":false,"excerpt":"JetBlue Flight 429 took off from Boston, Massachusetts on 11th August 2016, heading towards Sacramento in California. During the flight, the aircraft came into contact with extreme turbulence which forced the pilot to make an emergency landing in Rapid City, South Dakota. Once landed, 24 passengers and 3 crew members\u2026","rel":"","context":"In "Latest"","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"easyJet data breach claim","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/03\/headphones-explode-mid-flight.jpg?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/03\/headphones-explode-mid-flight.jpg?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/03\/headphones-explode-mid-flight.jpg?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/03\/headphones-explode-mid-flight.jpg?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1041,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/johnson-johnson-pays-319-million-latest-talcum-powder-claim","url_meta":{"origin":923,"position":2},"title":"Johnson & Johnson ordered to pay out over \u00a3300 million for “carcinogenic” talcum powder","author":"Admin","date":"25th October 2017","format":false,"excerpt":"Global healthcare company Johnson & Johnson have been ordered to pay around \u00a3319 million in damages to a woman after she developed ovarian cancer allegedly from using their talcum baby powder. The jury came to the conclusion that the company failed to warn consumers of the alleged risks associated with\u2026","rel":"","context":"In "Cosmetics"","block_context":{"text":"Cosmetics","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/cosmetics"},"img":{"alt_text":"talcum powder ovarian cancer link","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/talcum-powder-ovarian-cancer-link-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/talcum-powder-ovarian-cancer-link-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/talcum-powder-ovarian-cancer-link-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/talcum-powder-ovarian-cancer-link-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1251,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/allegations-that-herbalife-supplement-products-cause-liver-damage","url_meta":{"origin":923,"position":3},"title":"More allegations that Herbalife’s supplement products cause liver damage","author":"Admin","date":"8th January 2018","format":false,"excerpt":"In August 2017, a claim was filed by a woman against Herbalife on the basis that their products allegedly gave her liver damage. The claimant alleges that after taking their supplementary products for six years, she has sustained irreversible liver damage and will need to undergo a transplant. The lawsuit\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/health"},"img":{"alt_text":"herbal supplements claim","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/herbal-supplements-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/herbal-supplements-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/herbal-supplements-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/herbal-supplements-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1113,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/lidl-gravy-contaminated-paint-thinner-ingredient","url_meta":{"origin":923,"position":4},"title":"Lidl gravy was once found to have been contaminated with paint thinner ingredient!","author":"Admin","date":"24th November 2017","format":false,"excerpt":"Here's an unusual story from around this time last year. Reportedly, dangerous amounts of Xylene were found in Lidl's Kania Meat and Kania Chicken Gravy Granules, leading to Lidl recalling the products and offering full refunds to customers. As the countdown to Christmas has begun, one can only hope we\u2026","rel":"","context":"In "Food"","block_context":{"text":"Food","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/food"},"img":{"alt_text":"gravy","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gravy-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gravy-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gravy-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/gravy-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":37,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/false-results-from-hiv-testing-devices-investigation","url_meta":{"origin":923,"position":5},"title":"False results from HIV testing devices investigation","author":"Admin","date":"10th August 2016","format":false,"excerpt":"It has been discovered that certain devices manufactured by Hangzhou Biotest Biotech Co Ltd were giving incorrect results - false positives and \/ or false negatives - when testing for HIV, HCV and HBV. These tests are used in professional clinical settings, which include Sexual health clinics, General Practitioners, Genitourinary\u2026","rel":"","context":"In "Latest"","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=923"}],"version-history":[{"count":5,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/923\/revisions"}],"predecessor-version":[{"id":930,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/923\/revisions\/930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/926"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}